Decompensation of Pressure-Overload Hypertrophy in G??q-Overexpressing Mice, Circulation, vol.97, issue.15, pp.1488-95, 1998. ,
DOI : 10.1161/01.CIR.97.15.1488
Cardiac Hypertrophy: The Good, the Bad, and the Ugly, Annual Review of Physiology, vol.65, issue.1, pp.45-79, 2003. ,
DOI : 10.1146/annurev.physiol.65.092101.142243
Protein kinase cascades in the regulation of cardiac hypertrophy, Journal of Clinical Investigation, vol.115, issue.3, pp.527-564, 2005. ,
DOI : 10.1172/JCI24178
Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy, Circulation Research, vol.94, issue.1, pp.110-118, 2004. ,
DOI : 10.1161/01.RES.0000109415.17511.18
Homocystinuria: An Enzymatic Defect, Science, vol.143, issue.3613, pp.1443-1448, 1964. ,
DOI : 10.1126/science.143.3613.1443
Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis ,
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes, JAMA: The Journal of the American Medical Association, vol.274, issue.13, pp.1049-57, 1995. ,
DOI : 10.1001/jama.274.13.1049
Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease Effects of pyridoxine and folic acid treatment, Atherosclerosis, vol.81, issue.1, pp.51-60, 1990. ,
DOI : 10.1016/0021-9150(90)90058-Q
Labile methyl balances for normal humans on various dietary regimens, Metabolism, vol.24, issue.6, pp.721-755, 1975. ,
DOI : 10.1016/0026-0495(75)90040-2
Labile methyl group balances in the human: The role of sarcosine, Metabolism, vol.29, issue.8, pp.707-727, 1980. ,
DOI : 10.1016/0026-0495(80)90192-4
Glycine N-methyltransferase is a folate binding protein of rat liver cytosol., Proceedings of the National Academy of Sciences, vol.81, issue.12, pp.3631-3635, 1984. ,
DOI : 10.1073/pnas.81.12.3631
Clinical chemistry and molecular biology of homocysteine metabolism: An update, Clinical Biochemistry, vol.30, issue.3, pp.189-201, 1997. ,
DOI : 10.1016/S0009-9120(96)00172-5
-adenosylmethionine's co-ordinate regulation of homocysteine metabolism, Biochemical Journal, vol.298, issue.2, pp.415-424, 1994. ,
DOI : 10.1042/bj2980415
Effect of vitamin B-6 deficiency on fasting plasma homocysteine concentrations, The American Journal of Clinical Nutrition, vol.55, issue.6, pp.1154-60, 1992. ,
DOI : 10.1093/ajcn/55.6.1154
Vitamin B???6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats, The American Journal of Clinical Nutrition, vol.59, issue.5, pp.1033-1042, 1994. ,
DOI : 10.1093/ajcn/59.5.1033
Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolatereductase, Am J Hum Genet, vol.43, pp.414-435, 1988. ,
Homocysteine and coronary artery disease in French Canadian subjects: Relation with vitamins B12, B6, pyridoxal phosphate, and folate, The American Journal of Cardiology, vol.75, issue.16, pp.1107-1118, 1995. ,
DOI : 10.1016/S0002-9149(99)80739-5
Effect of various regimens of vitamin B6 and folic acid on mild hyperhomocysteinaemia in vascular patients, Journal of Inherited Metabolic Disease, vol.309, issue.1, pp.159-62, 1994. ,
DOI : 10.1007/BF00735426
Homocysteinemia due to folate deficiency, Metabolism, vol.36, issue.5, pp.458-62, 1987. ,
DOI : 10.1016/0026-0495(87)90043-6
Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations, The Lancet, vol.346, issue.8967, pp.858-867, 1995. ,
DOI : 10.1016/S0140-6736(95)92113-3
Vitamin Requirements for the Treatment of Hyperhomocysteinemia in Humans, The Journal of Nutrition, vol.124, issue.10, pp.1927-1960, 1994. ,
DOI : 10.1093/jn/124.10.1927
???ber den rationellen klinischen Umgang mit Homocystein, Fols???ure und B-Vitaminen bei kardiovaskul???ren und thrombotischen Erkrankungen, Zeitschrift f???r Kardiologie, vol.93, issue.6, pp.439-53, 2004. ,
DOI : 10.1007/s00392-004-0075-3
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population, JAMA: The Journal of the American Medical Association, vol.270, issue.22, pp.2693-2701, 1993. ,
DOI : 10.1001/jama.1993.03510220049033
10-methylenetetrahydrofolate reductas (MHTFR) Commonmutations, folate status and plasma homocysteine in healthy French adults of the SU.VI.MAX cohort, Br J Nutr, vol.5, issue.84, pp.891-894, 2000. ,
Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations, Genetic Epidemiology, vol.90, issue.4, pp.298-309, 1999. ,
DOI : 10.1093/qjmed/90.8.551
The methionine synthase reductase (MTRR) A66 polymorphism is a novel genetic determinant of plasma homocystéine concentrations ,
Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine Concentrations, Circulation, vol.93, issue.1, pp.7-9, 1996. ,
DOI : 10.1161/01.CIR.93.1.7
HOMOCYSTEINE AND CARDIOVASCULAR DISEASE, Annual Review of Medicine, vol.49, issue.1, pp.31-63, 1998. ,
DOI : 10.1146/annurev.med.49.1.31
Growth disorders and homocysteine metabolism, Ann Clin Lab Sci, vol.5, pp.147-52, 1975. ,
Plasma total homocysteine levels in hyperthyroid and hypothyroid patients, Metabolism, vol.47, issue.1, pp.89-93, 1998. ,
DOI : 10.1016/S0026-0495(98)90198-6
Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase, J Biol Chem, vol.27, pp.17012-17019, 1997. ,
Homocysteine potentiates ??-amyloid neurotoxicity: role of oxidative stress, Journal of Neurochemistry, vol.67, issue.2, pp.249-53, 2001. ,
DOI : 10.1046/j.1471-4159.1996.67041419.x
Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen., Journal of Clinical Investigation, vol.91, issue.1, pp.308-326, 1993. ,
DOI : 10.1172/JCI116187
Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activation of Nos2, Proc Assoc Am Physicians, vol.110, pp.22-31, 1998. ,
EDRF, and endothelial function, [39]. Jacobsen DW. Homocysteine and vitamins in cardiovascular disease, pp.12901833-12901876, 1996. ,
Effects of homocysteine on endothelial nitric oxide production, American Journal of Physiology-Renal Physiology, vol.277, issue.4, pp.671-679, 2000. ,
DOI : 10.1161/01.CIR.83.2.391
Hyperhomocyst(e)inemia Is Associated With Impaired Endothelium-Dependent Vasodilation in Humans, Circulation, vol.95, issue.5, pp.1119-1140, 1997. ,
DOI : 10.1161/01.CIR.95.5.1119
Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of c-fos and c-myb in smooth muscle cells., The FASEB Journal, vol.11, issue.8, pp.703-714, 1997. ,
DOI : 10.1096/fasebj.11.8.9240971
Homocysteine exerts cell type-specific inhibition of AP-1 transcription factor, Free Radical Biology and Medicine, vol.28, issue.1, pp.39-45, 2000. ,
DOI : 10.1016/S0891-5849(99)00200-2
Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model, Journal of Clinical Investigation, vol.107, issue.6, pp.675-83, 2001. ,
DOI : 10.1172/JCI10588
Homocysteine and lipid metabolism in atherogenesis: effect of the homocysteine thiolactonyl derivatives, thioretinaco and thioretinamide, Atherosclerosis, vol.83, issue.2-3, pp.197-206, 1990. ,
DOI : 10.1016/0021-9150(90)90165-F
Homocysteine and Hemostasis: Pathogenetic Mechanisms Predisposing to Thrombosis, The Journal of Nutrition, vol.126, issue.suppl_4, pp.1285-1294, 1996. ,
DOI : 10.1093/jn/126.suppl_4.1285S
Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta, British Journal of Pharmacology, vol.96, issue.4, pp.1034-1074, 1999. ,
DOI : 10.1161/01.CIR.96.8.2542
Demonstration of Rapid Onset Vascular Endothelial Dysfunction After Hyperhomocysteinemia : An Effect Reversible With Vitamin C Therapy, Circulation, vol.99, issue.9, pp.1156-60, 1999. ,
DOI : 10.1161/01.CIR.99.9.1156
Characteristics of catechol O-methyltransferase (COMT) and properties of selective COMT inhibitors, Prog Drug Res, vol.39, pp.291-350, 1992. ,
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis., Proceedings of the National Academy of Sciences, vol.91, issue.14, pp.6369-73, 1994. ,
DOI : 10.1073/pnas.91.14.6369
Homocysteine decreases chondrocyte-mediated matrix mineralization in differentiating chick limb-bud mesenchymal cell micro-mass cultures, Bone, vol.28, issue.4, pp.387-98, 2001. ,
DOI : 10.1016/S8756-3282(01)00409-4
Left ventricular systolic dysfunction is an independent predictor of homocysteine in angiographically documented patients with or without coronary artery lesions, Journal of Thrombosis and Haemostasis, vol.5, issue.suppl 4, pp.1209-1225, 2007. ,
DOI : 10.1152/ajpheart.00475.2002
Homocysteine and heart failure: a review of investigations from the Framingham Heart Study Reed JC. Mechanisms of apoptosis Apoptosis in cardiac disease, Apoptosis in myocytes in end-stage heart failure, pp.987-992, 1996. ,
Apoptosis in the Failing Human Heart, New England Journal of Medicine, vol.336, issue.16, pp.1131-1172, 1997. ,
DOI : 10.1056/NEJM199704173361603
Apoptosis and Heart Failure : A Critical Review of the Literature, Circulation Research, vol.86, issue.11, pp.1107-1120, 2000. ,
DOI : 10.1161/01.RES.86.11.1107
Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat, American Journal of Physiology-Heart and Circulatory Physiology, vol.272, issue.5, pp.2313-2322, 1997. ,
DOI : 10.1152/ajpheart.1997.272.5.H2313
Loss of a gp130 Cardiac Muscle Cell Survival Pathway Is a Critical Event in the Onset of Heart Failure during Biomechanical Stress, Cell, vol.97, issue.2, pp.189-98, 1999. ,
DOI : 10.1016/S0092-8674(00)80729-1
A mechanistic role for cardiac myocyte apoptosis in heart failure, Journal of Clinical Investigation, vol.111, issue.10, pp.1497-504, 2003. ,
DOI : 10.1172/JCI17664
Beta-adrenergic agonists stimulate the synthesis of noncontractile but not contractile proteins in cultured myocytes isolated from adult rat heart, Circulation Research, vol.66, issue.3, pp.867-74, 1990. ,
DOI : 10.1161/01.RES.66.3.867
Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice, Circulation J Mol Cell Cardiol, vol.9867, issue.32, pp.1329-1363, 1998. ,
Coupling of ??2-Adrenoceptor to Gi Proteins and Its Physiological Relevance in Murine Cardiac Myocytes, Circulation Research, vol.84, issue.1, pp.43-52, 1999. ,
DOI : 10.1161/01.RES.84.1.43
Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the p38 Mitogen-activated Protein Kinase Family, Journal of Biological Chemistry, vol.272, issue.4, pp.2161-2169, 1998. ,
DOI : 10.1016/S0092-8674(00)81878-4
p38 mitogen-activated protein kinase pathway protects adult rat ventricular myocytes against beta-adrenergic receptor-stimulated apoptosis. Evidence for Gi-dependent activation ,
beta-Adrenergic Receptor-Stimulated Apoptosis in Cardiac Myocytes Is Mediated by Reactive Oxygen Species/c-Jun NH2-Terminal Kinase-Dependent Activation of the Mitochondrial Pathway, Circulation Research, vol.92, issue.2, pp.136-144, 2003. ,
DOI : 10.1161/01.RES.0000054624.03539.B4
beta1 integrins expression in adult rat ventricular myocytes and its role in the regulation of beta-adrenergic receptor-stimulated apoptosis Neurohormonal regulation of myocardial cell apoptosis during the development of heart failure, J Cell Biochem J Cell Physiol, vol.8973, issue.186, pp.381-389, 2001. ,
Evidence of Apoptosis in Arrhythmogenic Right Ventricular Dysplasia, New England Journal of Medicine, vol.335, issue.16, pp.1190-1196, 1996. ,
DOI : 10.1056/NEJM199610173351604
Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy, Proceedings of the National Academy of Sciences, vol.57, issue.12, pp.8144-8153, 1999. ,
DOI : 10.1253/jcj.57.1150
Oxidative Stress-Mediated Cardiac Cell Death Is a Major Determinant of Ventricular Dysfunction and Failure in Dog Dilated Cardiomyopathy, Circulation Research, vol.89, issue.3, pp.279-86, 2001. ,
DOI : 10.1161/hh1501.094115
Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function, Proceedings of the National Academy of Sciences, vol.6, issue.11, pp.9977-82, 2001. ,
DOI : 10.1038/sj.cdd.4400596
Morphological and Molecular Characterization of Adult Cardiomyocyte Apoptosis During Hypoxia and Reoxygenation, Circulation Research, vol.87, issue.2, pp.118-143, 2000. ,
DOI : 10.1161/01.RES.87.2.118
Time Course of the Apoptotic Cascade and Effects of Caspase Inhibitors in Adult Rat Ventricular Cardiomyocytes, Journal of Molecular and Cellular Cardiology, vol.33, issue.5, pp.983-94, 2001. ,
DOI : 10.1006/jmcc.2001.1364
Direct Evidence for Increased Hydroxyl Radicals Originating From Superoxide in the Failing Myocardium, Circulation Research, vol.86, issue.2, pp.152-159, 2000. ,
DOI : 10.1161/01.RES.86.2.152
Peroxynitrite: Toxic or Protective in the Heart?, Circulation Research, vol.88, issue.2, pp.12-15, 2001. ,
DOI : 10.1161/01.RES.88.2.e12
Mitochondrial Electron Transport Complex I Is a Potential Source of Oxygen Free Radicals in the Failing Myocardium, Circulation Research, vol.85, issue.4, pp.357-63, 1999. ,
DOI : 10.1161/01.RES.85.4.357
-isocitrate Dehydrogenase Is Inactivated through 4-Hydroxynonenal Adduct Formation, Journal of Biological Chemistry, vol.30, issue.182, pp.45154-45163, 2003. ,
DOI : 10.1016/S0022-2828(03)00145-7
Mitochondrial DNA Damage and Dysfunction Associated With Oxidative Stress in Failing Hearts After Myocardial Infarction, Circulation Research, vol.88, issue.5, pp.529-564, 2001. ,
DOI : 10.1161/01.RES.88.5.529
Mediator-induced activation of xanthine oxidase in endothelial cells., The FASEB Journal, vol.3, issue.13, pp.2512-2520, 1989. ,
DOI : 10.1096/fasebj.3.13.2806779
Peroxynitrite Induces the Conversion of Xanthine Dehydrogenase to Oxidase in Rabbit Liver, Biochemical and Biophysical Research Communications, vol.230, issue.2, pp.476-485, 1997. ,
DOI : 10.1006/bbrc.1996.5983
Xanthine oxidoreductase activity in perfused hearts of various species, including humans, Circulation Research, vol.67, issue.3, pp.770-773, 1990. ,
DOI : 10.1161/01.RES.67.3.770
Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy, Circulation, vol.104, issue.20, pp.2407-2418, 2001. ,
DOI : 10.1161/hc4501.098928
Intravenous Allopurinol Decreases Myocardial Oxygen Consumption and Increases Mechanical Efficiency in Dogs With Pacing-Induced Heart Failure, Circulation Research, vol.85, issue.5 ,
DOI : 10.1161/01.RES.85.5.437
Neutrophil superoxide anion???generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy, Journal of the American College of Cardiology, vol.36, issue.5, pp.1474-82, 2000. ,
DOI : 10.1016/S0735-1097(00)00916-5
- production, Thrombosis and Haemostasis, vol.90, pp.317-342, 2003. ,
DOI : 10.1160/TH03-02-0105
Reactive Oxygen Species, Mitochondria, and NAD(P)H Oxidases in the Development and Progression of Heart Failure, Congestive Heart Failure, vol.100, issue.4, pp.132-172, 2002. ,
DOI : 10.1161/01.CIR.100.3.292
Catecholamine-Induced Vascular Wall Growth Is Dependent on Generation of Reactive Oxygen Species, Circulation Research, vol.94, issue.1, pp.37-45, 2004. ,
DOI : 10.1161/01.RES.0000109412.80157.7D
-adrenoceptor signaling in adult rat cardiac myocytes, American Journal of Physiology-Cell Physiology, vol.49, issue.4, pp.926-960, 2002. ,
DOI : 10.1016/S0014-2999(99)00222-8
Activation of NADPH Oxidase During Progression of Cardiac Hypertrophy to Failure, Hypertension, vol.40, issue.4, pp.477-84, 2002. ,
DOI : 10.1161/01.HYP.0000032031.30374.32
Oxygen Free Radical Release in Human Failing Myocardium Is Associated With Increased Activity of Rac1-GTPase and Represents a Target for Statin Treatment, Circulation, vol.108, issue.13, pp.1567-74, 2003. ,
DOI : 10.1161/01.CIR.0000091084.46500.BB
Increased myocardial NADPH oxidase activity in human heart failure, Journal of the American College of Cardiology, vol.41, issue.12, pp.2164-71, 2003. ,
DOI : 10.1016/S0735-1097(03)00471-6
Impact of NAD(P)H Oxidase-Derived Reactive Oxygen Species on Coronary Arterial Remodeling: A Comparative Intravascular Ultrasound and Histochemical Analysis of Atherosclerotic Lesions, Circulation: Cardiovascular Interventions, vol.2, issue.3, pp.196-204, 2009. ,
DOI : 10.1161/CIRCINTERVENTIONS.108.799502
Increased Oxidative Stress in Patients With Congestive Heart Failure 11This study was supported by a grant jointly sponsored by the Medical Research Council of Canada, Ottawa and Bayer Pharmaceuticals, Etobicoke, Ontario, Canada., Journal of the American College of Cardiology, vol.31, issue.6, pp.1352-1358, 1998. ,
DOI : 10.1016/S0735-1097(98)00101-6
Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice., Proceedings of the National Academy of Sciences, vol.93, issue.18, pp.9782-9789, 1996. ,
DOI : 10.1073/pnas.93.18.9782
Overexpression of Glutathione Peroxidase Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice, Circulation, vol.109, issue.4, pp.544-553, 2004. ,
DOI : 10.1161/01.CIR.0000109701.77059.E9
Carnitine: a nutritional, biosynthetic, and functional perspective, Molecular Aspects of Medicine, vol.25, issue.5-6, pp.455-73, 2004. ,
DOI : 10.1016/j.mam.2004.06.006
Reversible enzymatic acetylation of carnitine, Archives of Biochemistry and Biophysics, vol.59, issue.2, pp.491-501, 1955. ,
DOI : 10.1016/0003-9861(55)90515-4
PPAR agonists as direct modulators of the vessel wall in cardiovascular disease, Medicinal Research Reviews, vol.77, issue.5, pp.350-366, 2000. ,
DOI : 10.1161/01.ATV.13.4.571
CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors, Circulation, vol.101, issue.20, pp.2411-2417, 2000. ,
DOI : 10.1161/01.CIR.101.20.2411
Nuclear Receptor Peroxisome Proliferator-activated Receptor ?? (PPAR??) Is Expressed in Resting Murine Lymphocytes, Journal of Biological Chemistry, vol.270, issue.9, pp.6838-6845, 2002. ,
DOI : 10.1161/01.HYP.36.5.851
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease, Journal of Clinical Investigation, vol.116, issue.3, pp.615-637, 2006. ,
DOI : 10.1172/JCI27794
M??nage-??-Trois 1 Is Critical for the Transcriptional Function of PPAR?? Coactivator 1, Cell Metabolism, vol.5, issue.2, pp.129-171, 2007. ,
DOI : 10.1016/j.cmet.2007.01.003
Coordinate Regulation of the Expression of the Fatty Acid Transport Protein and Acyl-CoA Synthetase Genes by PPAR?? and PPAR?? Activators, Journal of Biological Chemistry, vol.270, issue.45, pp.28210-28217, 1997. ,
DOI : 10.1172/JCI117717
Identification of a Functional Peroxisome Proliferator-responsive Element in the Murine Fatty Acid Transport Protein Gene, Journal of Biological Chemistry, vol.267, issue.7, pp.3970-3977, 1999. ,
DOI : 10.1016/0960-0760(93)90058-5
Induction of the Acyl-Coenzyme A Synthetase Gene by Fibrates and Fatty Acids Is Mediated by a Peroxisome Proliferator Response Element in the C Promoter, Journal of Biological Chemistry, vol.267, issue.33, pp.19269-19276, 1995. ,
DOI : 10.1146/annurev.nu.14.070194.000503
Fatty Acids Activate Transcription of the Muscle Carnitine Palmitoyltransferase I Gene in Cardiac Myocytes via the Peroxisome Proliferator-activated Receptor ??, Journal of Biological Chemistry, vol.235, issue.37, pp.23786-23792, 1998. ,
DOI : 10.1074/jbc.273.15.8560
Control of Human Muscle-type Carnitine Palmitoyltransferase I Gene Transcription by Peroxisome Proliferator-activated Receptor, Journal of Biological Chemistry, vol.269, issue.15, pp.8560-8563, 1998. ,
DOI : 10.2337/diab.46.7.1230
A potent PPAR?? agonist stimulates mitochondrial fatty acid ??-oxidation in liver and skeletal muscle, American Journal of Physiology-Endocrinology and Metabolism, vol.255, issue.2, pp.270-279, 2001. ,
DOI : 10.1074/jbc.273.49.32901
Peroxisome Proliferator-Activated Receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, Modulate the Expression of Genes Involved in Cardiac Lipid Metabolism, Circulation Research, vol.92, issue.5, pp.518-524, 2003. ,
DOI : 10.1161/01.RES.0000060700.55247.7C
The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression., Proceedings of the National Academy of Sciences, vol.91, issue.23, pp.11012-11018, 1994. ,
DOI : 10.1073/pnas.91.23.11012
Altered Constitutive Expression of Fatty Acid-metabolizing Enzymes in Mice Lacking the Peroxisome Proliferator-activated Receptor ?? (PPAR??), Journal of Biological Chemistry, vol.83, issue.10, pp.5678-84, 1998. ,
DOI : 10.1016/0002-9343(87)90873-4
Isolation of pig mitochondrial 3-hydroxy-3- methylglutaryl-CoA synthase gene promoter : characterization of a peroxisome proliferator-responsive element ,
Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids, J Biol Chem, vol.269, pp.18767-72, 1994. ,
Transgenic mouse models of lipoprotein metabolism and atherosclerosis., Proceedings of the National Academy of Sciences, vol.90, issue.18, pp.8314-8322, 1993. ,
DOI : 10.1073/pnas.90.18.8314
Apolipoprotein B and Low-Density Lipoprotein Structure: Implications for Biosynthesis of Triglyceride-Rich Lipoproteins, Adv Protein Chem, vol.45, pp.205-253, 1994. ,
DOI : 10.1016/S0065-3233(08)60641-5
Thf complete amino acid sequence of C-I (apoLp- Ser), an apolipoprotein from human very low density lipoproteins, J Biol Chem, vol.250, pp.182-90, 1975. ,
Human apolipoprotein E. The complete amino acid sequence ,
Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism, Circulation, vol.98, issue.19, pp.2088-93, 1998. ,
DOI : 10.1161/01.CIR.98.19.2088
Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferatoractivated receptor with its response element, J Biol Chem, vol.269, pp.31012-31020, 1994. ,
Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor., Journal of Clinical Investigation, vol.96, issue.2, pp.741-50, 1995. ,
DOI : 10.1172/JCI118118
Alterations in Lipoprotein Metabolism in Peroxisome Proliferator-activated Receptor ??-deficient Mice, Journal of Biological Chemistry, vol.8, issue.43, pp.27307-27319, 1997. ,
DOI : 10.1074/jbc.270.33.19269
Down-regulation of hepatic lipase gene expression and activity by fenofibrate, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1123, issue.2, pp.227-257, 1992. ,
DOI : 10.1016/0005-2760(92)90115-C
Lecithin: cholesterol acyltransferase gene expression is regulated in a tissue-selective manner by fibrates, J Lipid Res, vol.33, pp.727-762, 1992. ,
Induction of the Phospholipid Transfer Protein Gene Accounts for the High Density Lipoprotein Enlargement in Mice Treated with Fenofibrate, Journal of Biological Chemistry, vol.37, issue.28, pp.25841-25848, 2001. ,
DOI : 10.1097/00041433-199906000-00007
Fibrates Down-regulate Hepatic Scavenger Receptor Class B Type I Protein Expression in Mice, Journal of Biological Chemistry, vol.41, issue.10, pp.7884-90, 2003. ,
DOI : 10.1074/jbc.M002310200
Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects, European Journal of Clinical Pharmacology, vol.40, issue.1, pp.57-63, 1983. ,
DOI : 10.1007/BF00544015
Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration, Atherosclerosis, vol.77, issue.2-3, pp.139-188, 1989. ,
DOI : 10.1016/0021-9150(89)90075-0
Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus, Clinica Chimica Acta, vol.373, issue.1-2, pp.127-158, 2006. ,
DOI : 10.1016/j.cca.2006.05.018
Vascular Stiffness: Measurements, Mechanisms and Implications, Current Vascular Pharmacology, vol.2, issue.4, pp.379-84, 2004. ,
DOI : 10.2174/1570161043385448
Familial neonatal isolated cardiomyopathy caused by a mutation in the flavoprotein subunit of succinate dehydrogenase, European Journal of Human Genetics, vol.93, issue.10, pp.1160-1165, 2010. ,
DOI : 10.1007/BF00711676
Developmental and Pathological Changes in the Human Cardiac Muscle Mitochondrial DNA Organization, Replication and Copy Number, PLoS ONE, vol.5, issue.5 ,
DOI : 10.1371/journal.pone.0010426.s002
Mitochondrial pathology in cardiac failure, Cardiovascular Research, vol.49, issue.1, pp.10426-14417, 2001. ,
DOI : 10.1016/S0008-6363(00)00241-8
Mitochondrial DNA analysis by multiplex denaturing high-performance liquid chromatography and selective sequencing in pediatric patients with cardiomyopathy, Genetics in Medicine, vol.355, issue.2, pp.118-144, 2009. ,
DOI : 10.1016/S0140-6736(99)05225-3
Efficiency of metabolic screening in childhood cardiomyopathies, European Heart Journal, vol.19, issue.5, pp.790-793, 1998. ,
DOI : 10.1053/euhj.1997.0818
Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy, European Heart Journal, vol.11, issue.6, pp.509-525, 1990. ,
DOI : 10.1093/oxfordjournals.eurheartj.a059743
Severe obstructive hypertrophic cardiomyopathy occurring secondary to mitochondrial disease, Turk Kardiyol Dern Ars, vol.37, pp.332-338, 2009. ,
Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy, Am J Pathol, vol.79, pp.387-434, 1975. ,
Severe hypotrophic and hypokinetic myocardiopathies secondary to obstructive malformations of the left heart infants, Arch Mal Coeur Vaiss, vol.76, pp.484-92, 1983. ,
Cardiomyopathies in disorders of oxidative metabolism, Cardiovascular Research, vol.35, issue.2, pp.184-99, 1997. ,
DOI : 10.1016/S0008-6363(97)00141-7
Histiocytoid Cardiomyopathy of Infancy, Pediatric Research, vol.18, issue.10, pp.1023-1031, 1984. ,
DOI : 10.1203/00006450-198418100-00023
Metabolic remodelling of the failing heart: beneficial or detrimental?, Cardiovascular Research, vol.314, issue.1, pp.420-428, 2009. ,
DOI : 10.1124/jpet.104.082636
The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury, American Heart Journal, vol.123, issue.2, pp.332-340, 1992. ,
DOI : 10.1016/0002-8703(92)90643-A
Adenosine A2-Receptor Activation at Reperfusion Reduces Infarct Size and Improves Myocardial Wall Function in Dog Heart, Journal of Cardiovascular Pharmacology, vol.22, issue.1, pp.89-96, 1993. ,
DOI : 10.1097/00005344-199307000-00015
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium, Circulation, vol.74, issue.5, pp.1124-1160, 1986. ,
DOI : 10.1161/01.CIR.74.5.1124
Angina reassessed: pain or protector?, The Lancet, vol.347, issue.9009, pp.1059-62, 1996. ,
DOI : 10.1016/S0140-6736(96)90613-3
A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers, Handb Exp Pharmacol, vol.193, pp.25-58, 2009. ,
DOI : 10.1007/978-3-540-89615-9_2
Mild Neonatal Hypoxia Exacerbates the Effects of Vitamin-Deficient Diet on Homocysteine Metabolism in Rats, Pediatric Research, vol.22, issue.6, pp.777-82, 2005. ,
DOI : 10.1007/s007260200000
URL : https://hal.archives-ouvertes.fr/hal-00466555
Immunoassay for single-stranded DNA in apoptotic cells, Methods Mol Biol, vol.282, pp.85-101, 2004. ,
A noninvasive computerized tail-cuff system for measuring blood pressure in mice, Hypertension, vol.25, pp.1111-1116, 1995. ,
Protein measurement with the Folin phenol reagent, J Biol Chem, vol.193, pp.265-75, 1951. ,
Demonstration That Mammalian Methionine Synthases Are Predominantly Cobalamin-loaded, Journal of Biological Chemistry, vol.86, issue.33, pp.19246-19255, 1995. ,
DOI : 10.1016/S0140-6736(95)90165-5
Mammalian methylenetetrahydrofolate reductase Partial purification, properties, and inhibition by S-adenosylmethionine, Biochimica et Biophysica Acta (BBA) - Enzymology, vol.250, issue.3, pp.459-477, 1971. ,
DOI : 10.1016/0005-2744(71)90247-6
Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase, J Lab Clin Med, vol.70, pp.158-69, 1967. ,
Assay of Aldehydes from Lipid Peroxidation: Gas Chromatography???Mass Spectrometry Compared to Thiobarbituric Acid, Analytical Biochemistry, vol.245, issue.2, pp.161-167, 1997. ,
DOI : 10.1006/abio.1996.9990
Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria*1, Hepatology, vol.19, issue.2, pp.471-479, 1994. ,
DOI : 10.1016/0270-9139(94)90027-2
Enzymatic and Polarographic Measurements of the Respiratory Chain Complexes, pp.357-377, 1999. ,
DOI : 10.1007/978-3-642-59884-5_27
Biochemical and molecular investigations in respiratory chain deficiencies, Clinica Chimica Acta, vol.228, issue.1, pp.35-51, 1994. ,
DOI : 10.1016/0009-8981(94)90055-8
A simple method for the isolation and purification of total lipides from animal tissues, J Biol Chem, vol.226, pp.497-509, 1957. ,
Hepatic Akt Activation Induces Marked Hypoglycemia, Hepatomegaly, and Hypertriglyceridemia With Sterol Regulatory Element Binding Protein Involvement, Diabetes, vol.52, issue.12, pp.2905-2923, 2003. ,
DOI : 10.2337/diabetes.52.12.2905
Simultaneous determination of purine nucleotides, their metabolites and ??-nicotinamide adenine dinucleotide in cerebellar granule cells by ion-pair high performance liquid chromatography, Brain Research Protocols, vol.10, issue.3, pp.168-74, 2003. ,
DOI : 10.1016/S1385-299X(02)00215-5
Simultaneous determination of six adenyl purines in human plasma by high-performance liquid chromatography with fluorescence derivatization, Journal of Chromatography B: Biomedical Sciences and Applications, vol.760, issue.1, pp.159-63, 2001. ,
DOI : 10.1016/S0378-4347(01)00265-1
Left ventricular systolic dysfunction is an independent predictor of homocysteine in angiographically documented patients with or without coronary artery lesions, Journal of Thrombosis and Haemostasis, vol.5, issue.suppl 4, pp.1209-1225, 2007. ,
DOI : 10.1152/ajpheart.00475.2002
Abstract, Clinical Chemical Laboratory Medicine, vol.1156, issue.12, pp.1633-1677, 2007. ,
DOI : 10.1515/CCLM.2003.222
URL : https://hal.archives-ouvertes.fr/hal-01375359
Plasma B vitamins and their relation to the severity of chronic heart failure, The American Journal of Clinical Nutrition, vol.26, issue.1, pp.117-140, 2007. ,
DOI : 10.1093/eurheartj/ehi442
Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease, Advances in Enzyme Regulation, vol.39, issue.1, pp.93-109, 1999. ,
DOI : 10.1016/S0065-2571(98)00029-6
Gestational Vitamin B Deficiency Leads to Homocysteine-Associated Brain Apoptosis and Alters Neurobehavioral Development in Rats, The American Journal of Pathology, vol.170, issue.2, pp.667-79, 2007. ,
DOI : 10.2353/ajpath.2007.060339
URL : https://hal.archives-ouvertes.fr/hal-00466548
Molecular Biology of the Natriuretic Peptide System: Implications for Physiology and Hypertension, Hypertension, vol.49, issue.3, pp.419-445, 2007. ,
DOI : 10.1161/01.HYP.0000258532.07418.fa
Cobalamin-mediated regulation of transcobalamin receptor levels in rat organs, Archives of Biochemistry and Biophysics, vol.463, issue.1, pp.128-160, 2007. ,
DOI : 10.1016/j.abb.2007.03.011
Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease Nutritional modulation of gene expression and homocysteine utilization by vitamin B12, Adv Enzyme Regul J Biol Chem, vol.39183, issue.278, pp.93-10920778, 1999. ,
Homocysteine Increases Methionine Synthase mRNA Level in Caco-2 Cells, Cellular Physiology and Biochemistry, vol.14, issue.4-6, pp.407-421, 2004. ,
DOI : 10.1159/000080350
The nature of antioxidant defense mechanisms: a lesson from transgenic studies, Environmental Health Perspectives, vol.106, issue.Suppl 5, pp.1219-1247, 1998. ,
DOI : 10.1289/ehp.98106s51219
Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase, Journal of Biological Chemistry, vol.110, issue.27, pp.17012-17019, 1997. ,
DOI : 10.1172/JCI118771
Homocysteine as a modulator of platelet-derived growth factor action in vascular smooth muscle cells: a possible role for hydrogen peroxide, British Journal of Pharmacology, vol.70, issue.2, pp.269-74, 1997. ,
DOI : 10.1042/bj3140021
Cystathionine ?? Synthase Deficiency Promotes Oxidative Stress, Fibrosis, and Steatosis in Mice Liver, Gastroenterology, vol.128, issue.5, pp.1405-1420, 2005. ,
DOI : 10.1053/j.gastro.2005.02.034
Vitamin B12 deficiency reduces proliferation and promotes differentiation of neuroblastoma cells and up-regulates PP2A, proNGF, and TACE, Proceedings of the National Academy of Sciences, vol.391, issue.1, pp.21930-21935, 2009. ,
DOI : 10.1007/s00216-008-1953-8
Homocysteine and inflammation as main determinants of oxidative stress in the elderly, Free Radical Biology and Medicine, vol.46, issue.6, pp.737-781, 2009. ,
DOI : 10.1016/j.freeradbiomed.2008.11.002
Folate Deficiency and Plasma Homocysteine during Increased Oxidative Stress, New England Journal of Medicine, vol.357, issue.4, pp.421-423, 2007. ,
DOI : 10.1056/NEJMc066569
Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways, Journal of Clinical Investigation, vol.107, issue.10, pp.1263-73, 2001. ,
DOI : 10.1172/JCI11596
Preferential response of glutathione-related enzymes to folate-dependent changes in the redox state of rat liver, European Journal of Nutrition, vol.55, issue.Suppl 3, pp.204-216, 2007. ,
DOI : 10.1080/07315724.1993.10718293
Investigation of Relationship Between Reduced, Oxidized, and Protein-Bound Homocysteine and Vascular Endothelial Function in Healthy Human Subjects, Circulation Research, vol.89, issue.2 ,
DOI : 10.1161/hh1401.093459
Oxidant stress mechanism of homocysteine potentiating Con A-induced proliferation in murine splenic T lymphocytes, Cardiovascular Research, vol.53, issue.4, pp.1035-1077, 2002. ,
DOI : 10.1016/S0008-6363(01)00541-7
Redox Status and Protein Binding of Plasma Homocysteine and Other Aminothiols in Patients With Early-Onset Peripheral Vascular Disease : Homocysteine and Peripheral Vascular Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.15, issue.2, pp.232-272, 1995. ,
DOI : 10.1161/01.ATV.15.2.232
Oxidant stress mechanism of homocysteine potentiating Con A-induced proliferation in murine splenic T lymphocytes, Cardiovascular Research, vol.53, issue.4, pp.1035-1077, 0199. ,
DOI : 10.1016/S0008-6363(01)00541-7
Effects of a methyl-deficient diet on rat liver phosphatidylcholine biosynthesis Inhibition of lipopolysaccharide-stimulated TNF-alpha promoter activity by S-adenosylmethionine and 5'-methylthioadenosine, Can J Biochem Am J Physiol Gastrointest Liver Physiol, vol.59201287, pp.543-50, 1981. ,
Transcriptional control of mitochondrial biogenesis: the central role of PGC-1??, Cardiovascular Research, vol.279, issue.45, pp.208-225, 2008. ,
DOI : 10.1074/jbc.M406217200
URL : https://hal.archives-ouvertes.fr/inserm-00290124
Farabee MJ. The Nature of ATP and Biological Energy The role of ADP receptors in platelet function, Serial on the Internet Front Biosci, vol.7, issue.11, pp.1977-86, 2002. ,
Down-regulation of Hsp60 expression by RNAi impairs folding of medium-chain acyl-CoA dehydrogenase wild-type and disease-associated proteins, Molecular Genetics and Metabolism, vol.85, issue.4, pp.260-70, 2005. ,
DOI : 10.1016/j.ymgme.2005.04.003
Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death, Journal of Clinical Investigation, vol.107, issue.11, pp.1403-1412, 2001. ,
DOI : 10.1172/JCI12590
Alterations of Mitochondrial Enzymes Contribute to Cardiac Hypertrophy before Hypertension Development in Spontaneously Hypertensive Rats, Journal of Proteome Research, vol.8, issue.5, pp.2463-75, 2009. ,
DOI : 10.1021/pr801059u
Adipocyte Fatty Acid-Binding Protein Suppresses Cardiomyocyte Contraction: A New Link Between Obesity and Heart Disease, Circulation Research, vol.105, issue.4, pp.326-360, 2009. ,
DOI : 10.1161/CIRCRESAHA.109.200501
Heart Fatty Acid Binding Protein Is a Novel Regulator of Cardiac Myocyte Hypertrophy, Biochemical and Biophysical Research Communications, vol.205, issue.3, pp.1822-1850, 1994. ,
DOI : 10.1006/bbrc.1994.2882
Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate, Journal of Lipid Research, vol.42, issue.1, pp.144-53, 2003. ,
DOI : 10.1095/biolreprod64.6.1689
Simultaneous determination of adenosine, Sadenosylhomocysteine and S-adenosylmethionine in biological samples using solid-phase extraction and highperformance liquid chromatography, J Chromatogr B Biomed Sci Appl, vol.724, pp.231-239, 1999. ,
Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase, J Lab Clin Med, vol.70, pp.158-69, 1967. ,
Carnitine Deficiency Disorders in Children, Annals of the New York Academy of Sciences, vol.93, issue.1, pp.42-51, 2004. ,
DOI : 10.1196/annals.1320.004
Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter, Nature Genetics, vol.325, issue.1, pp.91-95, 1999. ,
DOI : 10.1038/325641a0
Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter, J Pharmacol Exp Ther, vol.290, pp.1482-92, 1999. ,
Pressure Overload-Induced Cardiomyopathy in Heterozygous Carrier Mice of Carnitine Transporter Gene Mutation, Hypertension, vol.50, issue.3, pp.497-502, 2007. ,
DOI : 10.1161/HYPERTENSIONAHA.107.088609
Characteristics of Cardiac Hypertrophy in the Juvenile Visceral Steatosis Mouse with Systemic Carnitine Deficiency, Journal of Molecular and Cellular Cardiology, vol.30, issue.4, pp.773-81, 1998. ,
DOI : 10.1006/jmcc.1998.0641
Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter, Nature Genetics, vol.325, issue.1, pp.91-95, 1999. ,
DOI : 10.1038/325641a0
Organic cation/carnitine transporter family expression patterns in adult murine heart, Pathology - Research and Practice, vol.205, issue.6, pp.395-402, 2009. ,
DOI : 10.1016/j.prp.2008.12.010
A simple method for the isolation and purification of total lipides from animal tissues, J Biol Chem, vol.226, pp.497-509, 1957. ,
Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria*1, Hepatology, vol.19, issue.2, pp.471-480, 1994. ,
DOI : 10.1016/0270-9139(94)90027-2
The PPAR trio: Regulators of myocardial energy metabolism in health and disease, Journal of Molecular and Cellular Cardiology, vol.44, issue.6, pp.968-75, 2008. ,
DOI : 10.1016/j.yjmcc.2008.03.021
Evidence for mitochondrial thioesterase 1 as a peroxisome proliferator-activated receptor-alpha-regulated gene in cardiac and skeletal muscle ,
Altered Constitutive Expression of Fatty Acid-metabolizing Enzymes in Mice Lacking the Peroxisome Proliferator-activated Receptor ?? (PPAR??), Journal of Biological Chemistry, vol.83, issue.10, pp.5678-84, 1998. ,
DOI : 10.1016/0002-9343(87)90873-4
PPAR??-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation, Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol.1767, issue.9, pp.1134-1176, 2007. ,
DOI : 10.1016/j.bbabio.2007.07.001
Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins, Biochemical Journal, vol.382, issue.1, pp.239-284, 2004. ,
DOI : 10.1042/BJ20031340
Peroxisome proliferator-activated receptor ?? and its response element are required but not sufficient for transcriptional activation of the mouse heart-type fatty acid binding protein gene, The International Journal of Biochemistry & Cell Biology, vol.37, issue.7, pp.1534-1580, 2005. ,
DOI : 10.1016/j.biocel.2005.02.011
Elevated Homocysteine Reduces Apolipoprotein A-I Expression in Hyperhomocysteinemic Mice and in Males With Coronary Artery Disease, Circulation Research, vol.98, issue.4, pp.564-71, 2006. ,
DOI : 10.1161/01.RES.0000204825.66410.0b
Homocysteine-Mediated PPAR??,?? DNA Methylation and Its Potential Pathogenic Mechanism in Monocytes, DNA and Cell Biology, vol.27, issue.3, pp.143-50, 2008. ,
DOI : 10.1089/dna.2007.0658
Uptake of Cardiovascular Drugs Into the Human Heart: Expression, Regulation, and Function of the Carnitine Transporter OCTN2 (SLC22A5), Circulation, vol.113, issue.8, p.2 ,
DOI : 10.1161/CIRCULATIONAHA.105.586107
Peroxisome Proliferator-Activated Receptor-?? Coactivator 1?? (PGC-1??): Transcriptional Coactivator and Metabolic Regulator, Endocrine Reviews, vol.24, issue.1, pp.78-90, 2003. ,
DOI : 10.1210/er.2002-0012
URL : https://academic.oup.com/edrv/article-pdf/24/1/78/8861037/edrv0078.pdf
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis, Cell, vol.92, issue.6, pp.829-868, 1998. ,
DOI : 10.1016/S0092-8674(00)81410-5
Cloning and mRNA tissue distribution of human PPAR?? coactivator-1, International Journal of Obesity, vol.23, issue.12, pp.1327-1359, 1999. ,
DOI : 10.1038/sj.ijo.0801106
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1, Nature, vol.106, issue.6852, pp.131-139, 2001. ,
DOI : 10.1172/JCI10268
Suppression of ?? Cell Energy Metabolism and Insulin Release by PGC-1??, Developmental Cell, vol.5, issue.1, pp.73-83, 2003. ,
DOI : 10.1016/S1534-5807(03)00170-9
Peroxisome proliferator-activated receptor ????coactivator-1-dependent uncoupling protein-2 expression in pancreatic islets of rats: a novel pathway for neural control of insulin secretion, Diabetologia, vol.46, issue.11, pp.1522-1553, 2003. ,
DOI : 10.1007/s00125-003-1222-5
The estrogen-related receptor ?? (ERR??) functions in PPAR?? coactivator 1?? (PGC-1??)-induced mitochondrial biogenesis, Proceedings of the National Academy of Sciences, vol.100, issue.21, pp.6472-6479, 2004. ,
DOI : 10.1073/pnas.2135217100
Endurance Training in Humans Leads to Fiber Type-Specific Increases in Levels of Peroxisome Proliferator-Activated Receptor-?? Coactivator-1 and Peroxisome Proliferator-Activated Receptor-?? in Skeletal Muscle, Diabetes, vol.52, issue.12, pp.2874-81, 2003. ,
DOI : 10.2337/diabetes.52.12.2874
Peroxisome proliferator???activated receptor ?? coactivator-1 promotes cardiac mitochondrial biogenesis, Journal of Clinical Investigation, vol.106, issue.7, pp.847-56, 2000. ,
DOI : 10.1172/JCI10268
Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1, Cell, vol.98, issue.1, pp.115-139, 1999. ,
DOI : 10.1016/S0092-8674(00)80611-X
Acquirement of Brown Fat Cell Features by Human White Adipocytes, Journal of Biological Chemistry, vol.14, issue.35, pp.33370-33376, 2003. ,
DOI : 10.1042/cs0900243
The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor alpha in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes, Molecular and Cellular Biology, vol.20, issue.5 ,
DOI : 10.1128/MCB.20.5.1868-1876.2000
Involvement of Carnitine/organic Cation Transporter OCTN2 (SLC22A5) in Distribution of its Substrate Carnitine to the Heart, Drug Metabolism and Pharmacokinetics, vol.23, issue.3, pp.207-222, 2008. ,
DOI : 10.2133/dmpk.23.207
Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database Homocysteine lowering and cardiovascular events after acute myocardial infarction, BMJ N Engl J Med, vol.339, issue.354, pp.1578-88, 2006. ,
Homocysteine lowering with folic acid and B vitamins in vascular disease, N Engl J Med, vol.354, pp.1567-77, 2006. ,
Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, vol.117, pp.25-146, 2008. ,
Cardiovascular disease in Europe, European Journal of Cardiovascular Prevention & Rehabilitation, vol.353, issue.2_suppl, pp.43-50, 2009. ,
DOI : 10.1016/S0140-6736(99)04021-0
Edinburgh Artery Study: Prevalence of Asymptomatic and Symptomatic Peripheral Arterial Disease in the General Population, International Journal of Epidemiology, vol.20, issue.2, pp.384-92, 1991. ,
DOI : 10.1093/ije/20.2.384
AHA Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic) ,
Association of Novel Risk Factors With the Ankle Brachial Index in African American and Non-Hispanic White Populations, Mayo Clinic Proceedings, vol.82, issue.6, pp.709-725, 2007. ,
DOI : 10.1016/S0025-6196(11)61191-9
Elevated Levels of Inflammation, D-Dimer, and Homocysteine Are Associated With Adverse Calf Muscle Characteristics and Reduced Calf Strength in Peripheral Arterial Disease, Journal of the American College of Cardiology, vol.50, issue.9, pp.897-905, 2007. ,
DOI : 10.1016/j.jacc.2007.05.017
Biomarkers of Inflammation and Thrombosis as Predictors of Near-Term Mortality in Patients with Peripheral Arterial Disease: A Cohort Study, Annals of Internal Medicine, vol.148, issue.2, pp.85-93, 2008. ,
DOI : 10.7326/0003-4819-148-2-200801150-00003
Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes, Circulation, vol.85, issue.1, pp.30-36, 1992. ,
DOI : 10.1161/01.CIR.85.1.30
Novel Risk Factors for Systemic Atherosclerosis, JAMA, vol.285, issue.19, pp.2481-2486, 2001. ,
DOI : 10.1001/jama.285.19.2481
Serum homocysteine and the severity of coronary artery disease, Thrombosis Research, vol.111, issue.1-2, pp.55-62, 2003. ,
DOI : 10.1016/j.thromres.2003.08.015
Homocysteine and thrombosis: from basic science to clinical evidence, Thrombosis and Haemostasis ,
DOI : 10.1160/TH05-05-0313
Homocysteine and Peripheral Arterial Disease: Systematic Review and Meta-analysis, European Journal of Vascular and Endovascular Surgery, vol.38, issue.3, pp.316-338, 2009. ,
DOI : 10.1016/j.ejvs.2009.05.007
Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance, Circulation Circ Res, vol.101265, issue.99, pp.598-606, 2000. ,
Ankle-Brachial Index and Subclinical Cardiac and Carotid Disease, American Journal of Epidemiology, vol.162, issue.1, pp.33-41, 2005. ,
DOI : 10.1016/j.atherosclerosis.2003.09.015
Vitamin B12 deficiency reduces proliferation and promotes differentiation of neuroblastoma cells and upregulates PP2A, proNGF and TACE, Proc Natl Acad Sci U S A, vol.106, pp.21930-21935, 2009. ,
Association of MTRRA66G polymorphism (but not of MTHFR C677T and A1298C, MTRA2756G, TCN C776G) with homocysteine and coronary artery disease in the French population, Thromb Haemost, vol.94, pp.510-515, 2005. ,
Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin, Clin Chem, vol.41, pp.717-740, 1995. ,
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, vol.18, pp.499-502, 1972. ,
Opposite Effects of Cholesteryl Ester Transfer Protein and Phospholipid Transfer Protein on the Size Distribution of Plasma High Density Lipoproteins, Journal of Biological Chemistry, vol.111, issue.32, pp.19058-65, 1996. ,
DOI : 10.1016/0021-9150(85)90040-1
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group, Circulation, vol.88, issue.3, pp.837-882, 1993. ,
DOI : 10.1161/01.CIR.88.3.837
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), European Journal of Vascular and Endovascular Surgery, vol.33, issue.1, pp.1-75, 2007. ,
DOI : 10.1016/j.ejvs.2006.09.024
Symptomatic Peripheral Arterial Disease in Women: Nontraditional Biomarkers of Elevated Risk, Circulation, vol.117, issue.6, pp.823-854, 2008. ,
DOI : 10.1161/CIRCULATIONAHA.107.719369
Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials, European Heart Journal, vol.26, issue.2-3, pp.6-15, 2009. ,
DOI : 10.1016/j.jacc.2004.03.039
Daily Supplementation with (n-3) PUFAs, Oleic Acid, Folic Acid, and Vitamins B-6 and E Increases Pain-Free Walking Distance and Improves Risk Factors in Men with Peripheral Vascular Disease, The Journal of Nutrition, vol.109, issue.6, pp.1393-1402, 2005. ,
DOI : 10.1161/01.CIR.0000129138.08493.4D
Increased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, issue.12, pp.2054-60, 2009. ,
DOI : 10.1161/ATVBAHA.109.191320
Inhibition of Apolipoprotein AI Gene Expression by Tumor Necrosis Factor ??:?? Roles for MEK/ERK and JNK Signaling, Biochemistry, vol.45, issue.7, pp.2408-2421, 2006. ,
DOI : 10.1021/bi0518040
Relationships of HDL Cholesterol, ApoA-I, and ApoA-II With Homocysteine and Creatinine in Patients With Type 2 Diabetes Treated With Fenofibrate, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, issue.6 ,
DOI : 10.1161/ATVBAHA.108.178228
Homocysteine is not associated with arterial thickness and stiffness in healthy middle-aged French volunteers, International Journal of Cardiology, vol.113, issue.3, pp.332-372, 2006. ,
DOI : 10.1016/j.ijcard.2005.11.045
Circulating homocysteine and large arterial stiffness and thickness in a population-based sample of middle-aged and elderly men, Journal of Human Hypertension, vol.75, issue.12, pp.942-950, 2007. ,
DOI : 10.1016/j.atherosclerosis.2004.12.043
Molecular regulation of HDL metabolism and function: implications for novel therapies, Journal of Clinical Investigation, vol.116, issue.12, pp.3090-100, 2006. ,
DOI : 10.1172/JCI30163